Cargando…

IFN-Gamma Inhibits JC Virus Replication in Glial Cells by Suppressing T-Antigen Expression

OBJECTIVE: Patients undergoing immune modulatory therapies for the treatment of autoimmune diseases such as multiple sclerosis, and individuals with an impaired-immune system, most notably AIDS patients, are in the high risk group of developing progressive multifocal leukoencephalopathy (PML), an of...

Descripción completa

Detalles Bibliográficos
Autores principales: De-Simone, Francesca Isabella, Sariyer, Rahsan, Otalora, Yolanda-Lopez, Yarandi, Shadan, Craigie, Michael, Gordon, Jennifer, Sariyer, Ilker Kudret
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4465661/
https://www.ncbi.nlm.nih.gov/pubmed/26061652
http://dx.doi.org/10.1371/journal.pone.0129694
_version_ 1782376111312732160
author De-Simone, Francesca Isabella
Sariyer, Rahsan
Otalora, Yolanda-Lopez
Yarandi, Shadan
Craigie, Michael
Gordon, Jennifer
Sariyer, Ilker Kudret
author_facet De-Simone, Francesca Isabella
Sariyer, Rahsan
Otalora, Yolanda-Lopez
Yarandi, Shadan
Craigie, Michael
Gordon, Jennifer
Sariyer, Ilker Kudret
author_sort De-Simone, Francesca Isabella
collection PubMed
description OBJECTIVE: Patients undergoing immune modulatory therapies for the treatment of autoimmune diseases such as multiple sclerosis, and individuals with an impaired-immune system, most notably AIDS patients, are in the high risk group of developing progressive multifocal leukoencephalopathy (PML), an often lethal disease of the brain characterized by lytic infection of oligodendrocytes in the central nervous system (CNS) with JC virus (JCV). The immune system plays an important regulatory role in controlling JCV reactivation from latent sites by limiting viral gene expression and replication. However, little is known regarding the molecular mechanisms responsible for this regulation. METHODS AND RESULTS: Here, we investigated the impact of soluble immune mediators secreted by activated PBMCs on viral replication and gene expression by cell culture models and molecular virology techniques. Our data revealed that viral gene expression and viral replication were suppressed by soluble immune mediators. Further studies demonstrated that soluble immune mediators secreted by activated PBMCs inhibit viral replication induced by T-antigen, the major viral regulatory protein, by suppressing its expression in glial cells. This unexpected suppression of T-antigen was mainly associated with the suppression of translational initiation. Cytokine/chemokine array studies using conditioned media from activated PBMCs revealed several candidate cytokines with possible roles in this regulation. Among them, only IFN-γ showed a robust inhibition of T-antigen expression. While potential roles for IFN-β, and to a lesser extent IFN-α have been described for JCV, IFN-γ has not been previously implicated. Further analysis of IFN-γ signaling pathway revealed a novel role of Jak1 signaling in control of viral T-antigen expression. Furthermore, IFN-γ suppressed JCV replication and viral propagation in primary human fetal glial cells, and showed a strong anti-JCV activity. CONCLUSIONS: Our results suggest a novel role for IFN-γ in the regulation of JCV gene expression via downregulation of the major viral regulatory protein, T-antigen, and provide a new avenue of research to understand molecular mechanisms for downregulation of viral reactivation that may lead to development of novel strategies for the treatment of PML.
format Online
Article
Text
id pubmed-4465661
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-44656612015-06-25 IFN-Gamma Inhibits JC Virus Replication in Glial Cells by Suppressing T-Antigen Expression De-Simone, Francesca Isabella Sariyer, Rahsan Otalora, Yolanda-Lopez Yarandi, Shadan Craigie, Michael Gordon, Jennifer Sariyer, Ilker Kudret PLoS One Research Article OBJECTIVE: Patients undergoing immune modulatory therapies for the treatment of autoimmune diseases such as multiple sclerosis, and individuals with an impaired-immune system, most notably AIDS patients, are in the high risk group of developing progressive multifocal leukoencephalopathy (PML), an often lethal disease of the brain characterized by lytic infection of oligodendrocytes in the central nervous system (CNS) with JC virus (JCV). The immune system plays an important regulatory role in controlling JCV reactivation from latent sites by limiting viral gene expression and replication. However, little is known regarding the molecular mechanisms responsible for this regulation. METHODS AND RESULTS: Here, we investigated the impact of soluble immune mediators secreted by activated PBMCs on viral replication and gene expression by cell culture models and molecular virology techniques. Our data revealed that viral gene expression and viral replication were suppressed by soluble immune mediators. Further studies demonstrated that soluble immune mediators secreted by activated PBMCs inhibit viral replication induced by T-antigen, the major viral regulatory protein, by suppressing its expression in glial cells. This unexpected suppression of T-antigen was mainly associated with the suppression of translational initiation. Cytokine/chemokine array studies using conditioned media from activated PBMCs revealed several candidate cytokines with possible roles in this regulation. Among them, only IFN-γ showed a robust inhibition of T-antigen expression. While potential roles for IFN-β, and to a lesser extent IFN-α have been described for JCV, IFN-γ has not been previously implicated. Further analysis of IFN-γ signaling pathway revealed a novel role of Jak1 signaling in control of viral T-antigen expression. Furthermore, IFN-γ suppressed JCV replication and viral propagation in primary human fetal glial cells, and showed a strong anti-JCV activity. CONCLUSIONS: Our results suggest a novel role for IFN-γ in the regulation of JCV gene expression via downregulation of the major viral regulatory protein, T-antigen, and provide a new avenue of research to understand molecular mechanisms for downregulation of viral reactivation that may lead to development of novel strategies for the treatment of PML. Public Library of Science 2015-06-10 /pmc/articles/PMC4465661/ /pubmed/26061652 http://dx.doi.org/10.1371/journal.pone.0129694 Text en © 2015 De-Simone et al http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.
spellingShingle Research Article
De-Simone, Francesca Isabella
Sariyer, Rahsan
Otalora, Yolanda-Lopez
Yarandi, Shadan
Craigie, Michael
Gordon, Jennifer
Sariyer, Ilker Kudret
IFN-Gamma Inhibits JC Virus Replication in Glial Cells by Suppressing T-Antigen Expression
title IFN-Gamma Inhibits JC Virus Replication in Glial Cells by Suppressing T-Antigen Expression
title_full IFN-Gamma Inhibits JC Virus Replication in Glial Cells by Suppressing T-Antigen Expression
title_fullStr IFN-Gamma Inhibits JC Virus Replication in Glial Cells by Suppressing T-Antigen Expression
title_full_unstemmed IFN-Gamma Inhibits JC Virus Replication in Glial Cells by Suppressing T-Antigen Expression
title_short IFN-Gamma Inhibits JC Virus Replication in Glial Cells by Suppressing T-Antigen Expression
title_sort ifn-gamma inhibits jc virus replication in glial cells by suppressing t-antigen expression
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4465661/
https://www.ncbi.nlm.nih.gov/pubmed/26061652
http://dx.doi.org/10.1371/journal.pone.0129694
work_keys_str_mv AT desimonefrancescaisabella ifngammainhibitsjcvirusreplicationinglialcellsbysuppressingtantigenexpression
AT sariyerrahsan ifngammainhibitsjcvirusreplicationinglialcellsbysuppressingtantigenexpression
AT otalorayolandalopez ifngammainhibitsjcvirusreplicationinglialcellsbysuppressingtantigenexpression
AT yarandishadan ifngammainhibitsjcvirusreplicationinglialcellsbysuppressingtantigenexpression
AT craigiemichael ifngammainhibitsjcvirusreplicationinglialcellsbysuppressingtantigenexpression
AT gordonjennifer ifngammainhibitsjcvirusreplicationinglialcellsbysuppressingtantigenexpression
AT sariyerilkerkudret ifngammainhibitsjcvirusreplicationinglialcellsbysuppressingtantigenexpression